This morning on Heart of the Matter with Michael Grant
A Blood Test for CTE? Two New JAMA Studies Find a Tau Signal in Former Football Players, and Why It Isn't Ready for the Doctor's Office Yet
For the first time, researchers matched blood drawn from living players with what their brains showed after death. The early results are striking, the limits are real, and families finally have a reason for hope.
Filed November 20, 2026 · 📍 Boston, MA 02108
Were you there? Share your story
Key points
- A Boston University-led study of 21 former football players found a blood protein, eMTBR-tau, was much higher in those with advanced CTE.
- A separate Washington University study in the same journal found the same marker rose with the severity of CTE.
- Until now, CTE could only be confirmed by examining the brain after death.
- The test is not FDA-approved or available to the public, and researchers say it should not be used to diagnose anyone yet.
For two decades, chronic traumatic encephalopathy has been a diagnosis delivered too late to help. Families of former football players have watched loved ones struggle with memory, mood and behavior, and learned only after a funeral, when the brain was examined, what had been happening all along.
That may be starting to change. A study led by Boston University and published Nov. 19 in the Journal of the American Medical Association found that a protein measured in the blood was markedly higher in former players who turned out to have advanced CTE [1][2]. A second study in the same journal, from Washington University in St. Louis, pointed in the same direction [4].
CBS Boston reported that researchers called the finding a game changer [3]. They were just as clear that it is not ready for the doctor's office.
What the Boston Study Found
The Boston team studied 21 former American football players who gave blood samples while they were alive and, after they died, donated their brains to the BU CTE Center Brain Bank [1][3]. Twelve had played in the NFL, seven in college and two only in high school, according to the San Francisco Chronicle [2].
When the brains were examined, 18 of the 21 players had CTE and three did not [2][3]. Eleven of the 12 former professionals had high-stage CTE, as did four of the seven college players and one of the two high school players [2].
The researchers then looked back at the blood those men had given in life. Levels of a protein fragment called eMTBR-tau were significantly higher in the players with high-stage CTE than in those with low-stage CTE or no CTE at all [2][3]. The study was funded by the National Institutes of Health and involved the University of California, San Francisco, and more than a dozen other institutions [2].
Tau is a protein that normally helps hold brain cells' internal structure together. In CTE, abnormal tau builds up in the brain after years of repeated blows to the head [4]. A blood marker that tracks that buildup is exactly what researchers have been looking for.
A Second Study Points the Same Way
The Washington University study used a related approach. Its researchers had already linked a fragment called eMTBR-tau243 to Alzheimer's disease, and in the new JAMA paper they found it is also elevated in other brain diseases marked by the same kind of toxic tau buildup, CTE among them [4].
In 11 people whose CTE was confirmed at autopsy, levels of the fragment were higher than in healthy people and rose with the severity of the disease [4]. The test separated people with advanced CTE from healthy people with high accuracy, but it could not reliably pick out early-stage CTE [4].
The WashU team was candid about one complication: because Alzheimer's disease also raises the marker, the researchers said it will not work as a standalone test [4]. The university also disclosed that it and one of the lead researchers hold an ownership interest in C2N Diagnostics, the company that licensed the technology [4]. That kind of disclosure is exactly what readers should want to see in research that may one day be sold.
Why a Test in the Living Would Matter
Right now, the only way to confirm CTE is to examine brain tissue after death, as the New York Post noted in its report on the study [5]. That leaves living patients, their doctors and their families guessing.
The stakes of that guessing became clear in 2017, when Boston University researchers reported finding CTE in 110 of 111 brains of former NFL players donated to their brain bank [6]. That study had limits of its own: the brains came from families who chose to donate, often because their loved ones had shown symptoms, so it could not say how common CTE is among all players [6]. The same research team gathered histories from relatives after each death, and among the players with severe CTE, large majorities had shown behavioral or mood symptoms, problems with thinking and memory, and signs of dementia [6]. Those are the symptoms families describe living with for years without a name for them. Still, the 2017 findings changed the national conversation about football and the brain.
A reliable blood test could change the conversation again, in three ways. It could help doctors tell CTE apart from other causes of memory and mood problems, so patients get the right care. It could let researchers enroll living patients in trials of future treatments. And it could someday help families make better decisions about how long a son keeps playing a contact sport.
The Limits Researchers Themselves Flag
None of that is here yet. The Boston researchers stressed that the blood test is not approved by the Food and Drug Administration, is not available to the public and should not be used to diagnose CTE [3].
They also listed the study's weaknesses: a small sample of 21 people, few participants with low-stage CTE, and no age-matched comparison group [3]. Those are not small caveats. A test that works well in a few dozen brain donors may perform very differently in thousands of living people with all the ordinary health problems of middle and old age.
The WashU result adds a second warning. If a marker also rises with Alzheimer's disease, a high reading in a 70-year-old former lineman could mean more than one thing [4]. Any useful test will likely combine this marker with a doctor's examination, a careful history of head impacts and other measures.
There is also the question of timing. Both studies relied on blood drawn from people whose brains were later examined, which is the right way to prove a marker is tied to the disease [1][4]. The harder test comes next: following living former players for years, measuring the marker along the way, and seeing whether it predicts who develops symptoms. Only that kind of study can show whether the test helps a patient sitting in an exam room today.
What It Means for Players, Parents and Families
For former players and their families, the practical message is simple. Do not go looking for a CTE blood test today; reputable researchers say there is not one ready for patients [3]. If a loved one is struggling with memory, mood or behavior, see a physician, because many causes of those symptoms can be treated.
For parents of young athletes, the studies are a reminder that the brain deserves the same care we give a knee or a shoulder. One of the two high school-only players in the Boston study had high-stage CTE [2]. That single case proves nothing by itself, but it is worth remembering when deciding how much tackling a young player needs in practice, and how seriously to take every hit to the head.
Scripture calls the body a temple, and caring for it is part of honoring the One who made it. Football teaches courage, discipline and brotherhood, and millions of families love it for good reason. Better science about what the game does to the brain is not an attack on that tradition. It is how the tradition protects the men and boys who carry it on.
The next step is larger studies in living people, followed over time. If those confirm what these two small studies suggest, the generation now in pads may be the first to learn about CTE in time to do something about it.
Sources
- [1]The Boston GlobeCTE could be diagnosed using blood test, BU study findsOpens in a new tab ↗
- [2]San Francisco Chronicle'Major milestone': Study finds blood test can confirm CTE in living patientsOpens in a new tab ↗
- [3]Opens in a new tab ↗
- [4]Newswise (WashU Medicine)Progress toward a blood test for disease caused by CTEOpens in a new tab ↗
- [5]Opens in a new tab ↗
- [6]Boston UniversityBU Researchers Find CTE in 99% of Former NFL Players StudiedOpens in a new tab ↗
What worries you most about health care?
- Cost
- Getting an appointment
- Quality of care
- Government getting more involved
Were you there?
If you were at the scene, or this story touched your life, tell us what you saw and what it was like.



Discussion 0
Sign in or create a free account to join the discussion.
No comments yet. Start the discussion.